PI4Kbeta-IN-1 is an orally active and selective PI4Kbeta inhibitor, with an IC50 of 0.9 nM. PI4Kbeta-IN-1 exhibits inhibitory activity against all stages of the P. falciparum life cycle, including blood, liver, and transmission stages. PI4Kbeta-IN-1 demonstrates potent antimalarial efficacy in the mouse model infected with Plasmodium falciparum. PI4Kbeta-IN-1 can be used for the study of malaria caused by Plasmodium falciparum[1].
Molekulargewicht:
374.44
Formel:
C22H22N4O2
Target-Kategorie:
Parasite,PI4K
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten